| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3901814 | Urology | 2012 | 7 Pages |
Abstract
The results of the present study suggest that TGFBI-promoted metastasis of RCC cells depends on inactivation of the VHL tumor suppressor and that TGFBI could be a therapeutic target against RCC in the future.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Donghao Shang, Yuting Liu, Peiqian Yang, Yongqian Chen, Ye Tian,